Barmer-Apothekerin Heidi Gnther warnt generell vor der Anwendung der GLP-1-Rezeptoragonisten zur schnellen Gewichtsreduktion, wenn kein krankhaftes bergewicht besteht: Es ist immer mit Risiken verbunden, Medikamente nicht indikationsbezogen einzusetzen
These peptides work at the cellular level by supporting the bodys natural repair mechanisms
Clinical trials demonstrating semaglutides effectiveness typically ran for 68 weeks (approximately 16 months) or longer, with average weight loss of 14.9% of total body weight
GLP-1 agonists are not exact copies of the naturally occurring hormone and they can have negative side effects, including constipation, diarrhea, nausea, dizziness, abdominal pain, fatigue, hypoglycemia, allergic reactions, muscle wasting, gallstones, and increased risk of inflamed pancreas and thyroid cancer